Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srivastava, S.
Right arrow Articles by Henson, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srivastava, S.
Right arrow Articles by Henson, D. E.
Clinical Cancer Research Vol. 7, 1118-1126, May 2001
© 2001 American Association for Cancer Research


Minireview

Biomarkers for Early Detection of Colon Cancer

Sudhir Srivastava1, Mukesh Verma and Donald E. Henson

Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland 20852

There is an increasing demand for biomarkers in colon cancer for risk assessment, early detection, prognosis, and surrogate end points. A number of biomarkers have been identified for early detection of colon cancer, although the risk factors have not been identified extensively. The major advances in understanding colorectal cancer include the identification and the involvement of APC, p53, and Ki-ras in the development and progression of the disease, the identification of the aberrant crypt foci as an early preinvasive lesion, and its relation to the development of cancer. Detecting malignant neoplasms in the early stages offers clinical advantages; therefore, the National Cancer Institute has established an Early Detection Research Network. The emphasis of the network is on translational research and collaboration among scientists.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. K. Chan, O. L. Griffith, I. T. Tai, and S. J.M. Jones
Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 543 - 552.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. K. Roy and J. D. Khandekar
Biomarkers for the Early Detection of Cancer: An Inflammatory Concept
Arch Intern Med, September 24, 2007; 167(17): 1822 - 1824.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. L. Campbell, A. McTiernan, S. S. Li, B. E. Sorensen, Y. Yasui, J. W. Lampe, I. B. King, C. M. Ulrich, R. E. Rudolph, M. L. Irwin, et al.
Effect of a 12-Month Exercise Intervention on the Apoptotic Regulating Proteins Bax and Bcl-2 in Colon Crypts: A Randomized Controlled Trial
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1767 - 1774.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Z. Zhao, Y. Xiao, P. Elson, H. Tan, S. J. Plummer, M. Berk, P. P. Aung, I. C. Lavery, J. P. Achkar, L. Li, et al.
Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer
J. Clin. Oncol., July 1, 2007; 25(19): 2696 - 2701.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
P. Ellmark, J. Ingvarsson, A. Carlsson, B. S. Lundin, C. Wingren, and C. A. K. Borrebaeck
Identification of Protein Expression Signatures Associated with Helicobacter pylori Infection and Gastric Adenocarcinoma Using Recombinant Antibody Microarrays
Mol. Cell. Proteomics, September 1, 2006; 5(9): 1638 - 1646.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Bianco, L. Strizzi, M. Mancino, A. Rehman, S. Hamada, K. Watanabe, A. De Luca, B. Jones, G. Balogh, J. Russo, et al.
Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer
Clin. Cancer Res., September 1, 2006; 12(17): 5158 - 5164.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
X. Bi, Q. Lin, T. W. Foo, S. Joshi, T. You, H.-M. Shen, C. N. Ong, P. Y. Cheah, K. W. Eu, and C.-L. Hew
Proteomic Analysis of Colorectal Cancer Reveals Alterations in Metabolic Pathways: Mechanism of Tumorigenesis
Mol. Cell. Proteomics, June 1, 2006; 5(6): 1119 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J.-D. Luo, E.-C. Chan, C.-L. Shih, T.-L. Chen, Y. Liang, T.-L. Hwang, and C.-C. Chiou
Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe
Nucleic Acids Res., January 23, 2006; 34(2): e12 - e12.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Kovbasnjuk, R. Mourtazina, B. Baibakov, T. Wang, C. Elowsky, M. A. Choti, A. Kane, and M. Donowitz
The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer
PNAS, December 27, 2005; 102(52): 19087 - 19092.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Payne, H. Holubec, C. Bernstein, H. Bernstein, K. Dvorak, S. B. Green, M. Wilson, M. Dall'Agnol, B. Dvorakova, J. Warneke, et al.
Crypt-Restricted Loss and Decreased Protein Expression of Cytochrome c Oxidase Subunit I as Potential Hypothesis-Driven Biomarkers of Colon Cancer Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2066 - 2075.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Fujino, G. A. Vielhauer, and J. W. Regan
Prostaglandin E2 Selectively Antagonizes Prostaglandin F2{alpha}-stimulated T-cell Factor/{beta}-Catenin Signaling Pathway by the FPB Prostanoid Receptor
J. Biol. Chem., October 15, 2004; 279(42): 43386 - 43391.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Pereira, L. Tao, W. Wang, Y. Li, A. Umar, V. E. Steele, and R. A. Lubet
Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-{alpha} gene in rat colon tumors
Carcinogenesis, October 1, 2004; 25(10): 1917 - 1923.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. H. Carter, L. E. Douglass, J. A. Deddens, B. M. Colligan, T. R. Bhatt, J. O. Pemberton, S. Konicek, J. Hom, M. Marshall, and J. R. Graff
Pak-1 Expression Increases with Progression of Colorectal Carcinomas to Metastasis
Clin. Cancer Res., May 15, 2004; 10(10): 3448 - 3456.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-X. Qiao, M. Yuan, Y.-L. Liu, X.-S. Lin, X.-P. Zhang, and M. Tobi
Detection of Gastric Cancer and Premalignant Lesions by Novel Marker Glycoprotein 87 Using Monoclonal Antibody Adnab-9
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1095 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. A. Boynton, I. C. Summerhayes, D. A. Ahlquist, and A. P. Shuber
DNA Integrity as a Potential Marker for Stool-based Detection of Colorectal Cancer
Clin. Chem., July 1, 2003; 49(7): 1058 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Hashimoto, Y. He, and E. S. Yeung
On-line integration of PCR and cycle sequencing in capillaries: from human genomic DNA directly to called bases
Nucleic Acids Res., April 15, 2003; 31(8): e41 - e41.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.